4-butyrolactone has been researched along with thapsigargin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, SP; Ball, M; Ley, SV; Tait, MM | 1 |
| Fischer, H; Fu, Z; Illek, B; Machen, TE; Patanwala, M; Ravishankar, B; Schwarzer, C; Shuai, S | 1 |
2 other study(ies) available for 4-butyrolactone and thapsigargin
| Article | Year |
|---|---|
Design and total synthesis of unnatural analogues of the sub-nanomolar SERCA inhibitor thapsigargin.
Topics: 4-Butyrolactone; Drug Design; Enzyme Inhibitors; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Thapsigargin | 2007 |
Thapsigargin blocks Pseudomonas aeruginosa homoserine lactone-induced apoptosis in airway epithelia.
Topics: 4-Butyrolactone; Apoptosis; Calcium; Caspase 3; Caspase 7; Cell Line; Chelating Agents; Cytoprotection; Electric Impedance; Endoplasmic Reticulum; Enzyme Activation; Humans; Lung; Membrane Potential, Mitochondrial; Mitochondria; Primary Cell Culture; Protein Transport; Pseudomonas aeruginosa; Thapsigargin; Tight Junctions; Time Factors; Trachea; Zonula Occludens-1 Protein | 2014 |